Home LiteratureArticle Details
PMID: 3677050 Published · ppublish English Journal Article

Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings.

Cancer letters ·Vol. 37 ·No. 2 ·1987-10-30 ·Pages 147-51

Bird RP

Abstract

In the present study a methodological approach is taken which quantitates aberrant dysplastic crypts in the unsectioned murine colon. C57BL/6J or CF1 female mice (7-8 weeks old) were injected (i.p.) with azoxymethane (5 mg/kg body wt./week) for 4 weeks. Their colons were excised, cut open on the median axis and fixed flat in buffered formalin. Unsectioned colons were stained with methylene blue. The mucosal side was examined under a light microscope. The aberrant crypts, which are larger and have a thicker epithelial lining, were easily visualized using X 4 or X 10 objectives. CF1 mice, which are more sensitive to developing colon tumors, had a higher number of aberrant crypts/colon than their less sensitive counterparts, C57BL/6J mice (5.0 +/- 0.7 vs. 2.4 +/- 0.7). The usefulness of this observation as a possible measure of neoplastic events is discussed in the animal and human situation.

MeSH Terms
Animals Azoxymethane Colon/drug effects,pathology Colonic Neoplasms/chemically induced Female Mice Mice, Inbred C57BL
Chemicals
Azoxymethane
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Bird R P
Ludwig Institute for Cancer Research, Toronto Branch, Ontario, Canada.
Article Info
Journal
Cancer letters
Abbr.
Cancer Lett
ISSN
0304-3835
Published
1987-10-30
Pages
147-51
Language
English
Region
Ireland
NLM ID
7600053
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]